CL2013001853A1 - Bacteria no patogena gram negativa perteneciente a la clase betaproteobacteria y subfamilia neisseriaceae; extracto que la comprende; composicion que comprende a la bacteria o al extracto; y su uso para tratar o prevenir trastornos inflamatorios dermatologicos. - Google Patents

Bacteria no patogena gram negativa perteneciente a la clase betaproteobacteria y subfamilia neisseriaceae; extracto que la comprende; composicion que comprende a la bacteria o al extracto; y su uso para tratar o prevenir trastornos inflamatorios dermatologicos.

Info

Publication number: CL2013001853A1
Authority: CL; Chile
Prior art keywords: extract; betaproteobacteria; neisseriaceae; subfamily; bacteria
Prior art date: 2010-12-22

Application number

CL2013001853A

Other languages

English (en)

Inventor

Murial Bourrain

Nathalie Castex-Rizzi

Thien Nguyen

Philippe Lebaron

Original Assignee

Fabre Pierre Dermo Cosmetique

Univ Piere Et Marie Curie Paris 6

Centre Nat Rech Scient

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-12-22

Filing date

2013-06-21

Publication date

2014-03-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44359781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013001853(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-06-21 Application filed by Fabre Pierre Dermo Cosmetique, Univ Piere Et Marie Curie Paris 6, Centre Nat Rech Scient filed Critical Fabre Pierre Dermo Cosmetique

2014-03-28 Publication of CL2013001853A1 publication Critical patent/CL2013001853A1/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/36—Neisseria

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Birds (AREA)
Cosmetics (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

CL2013001853A 2010-12-22 2013-06-21 Bacteria no patogena gram negativa perteneciente a la clase betaproteobacteria y subfamilia neisseriaceae; extracto que la comprende; composicion que comprende a la bacteria o al extracto; y su uso para tratar o prevenir trastornos inflamatorios dermatologicos. CL2013001853A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR1061081A FR2969657B1 (fr)	2010-12-22	2010-12-22	Nouvelle bacterie et extraits de ladite bacterie et leur utilisation en dermatologie

Publications (1)

Publication Number	Publication Date
CL2013001853A1 true CL2013001853A1 (es)	2014-03-28

Family

ID=44359781

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2013001853A CL2013001853A1 (es)	2010-12-22	2013-06-21	Bacteria no patogena gram negativa perteneciente a la clase betaproteobacteria y subfamilia neisseriaceae; extracto que la comprende; composicion que comprende a la bacteria o al extracto; y su uso para tratar o prevenir trastornos inflamatorios dermatologicos.

Country Status (29)

Country	Link
US (2)	US9084811B2 (es)
EP (1)	EP2655595B1 (es)
JP (2)	JP6117111B2 (es)
KR (1)	KR102043472B1 (es)
CN (1)	CN103403144B (es)
AR (1)	AR084454A1 (es)
AU (1)	AU2011347254B2 (es)
CA (1)	CA2821653C (es)
CL (1)	CL2013001853A1 (es)
CO (1)	CO6741177A2 (es)
DK (1)	DK2655595T3 (es)
ES (1)	ES2689138T3 (es)
FR (1)	FR2969657B1 (es)
GE (1)	GEP201606589B (es)
IL (1)	IL226943B (es)
MA (1)	MA34734B1 (es)
MX (1)	MX345125B (es)
MY (1)	MY173066A (es)
NZ (1)	NZ612294A (es)
PH (1)	PH12013501267A1 (es)
PL (1)	PL2655595T3 (es)
PT (1)	PT2655595T (es)
RU (1)	RU2612790C2 (es)
SG (1)	SG191236A1 (es)
TN (1)	TN2013000249A1 (es)
TW (1)	TW201307551A (es)
UA (1)	UA113399C2 (es)
WO (1)	WO2012085182A1 (es)
ZA (1)	ZA201304355B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013190106A1 (en) *	2012-06-21	2013-12-27	Pierre Fabre Medicament	Use of a live bacterium for the treatment of intestinal inflammatory disorders
HK1223096A1 (zh)	2013-09-25	2017-07-21	Vertex Pharmaceuticals Incorporated	用作par-2信號通路抑制劑的咪唑並噠嗪
FR3065009B1 (fr) *	2017-04-06	2020-11-27	Fabre Pierre Dermo Cosmetique	Secretome bacterien pour son utilisation dans le traitement des lesions cutanees
FR3081705B1 (fr)	2018-06-01	2020-12-04	Fabre Pierre Dermo Cosmetique	Extrait et composition dermatologique le comprenant pour le traitement des peaux sensibles
FR3114024B1 (fr)	2020-09-11	2022-09-09	Fabre Pierre Dermo Cosmetique	Nouvelle émulsion mimant la peau
JP7695824B2 (ja) *	2021-06-02	2025-06-19	花王株式会社	皮膚細菌感染症の予防又は改善剤
JP7698983B2 (ja) *	2021-06-02	2025-06-26	花王株式会社	腸管感染症の予防又は改善剤
WO2024218205A1 (en) *	2023-04-18	2024-10-24	Pierre Fabre Dermo-Cosmetique	Novel bacterial strain useful for treating cutaneous inflammation
FR3150712A1 (fr)	2023-07-06	2025-01-10	Pierre Fabre Dermo-Cosmetique	Composition pour le traitement de désordres inflammatoires cutanés
FR3149774B1 (fr)	2024-01-11	2025-06-20	Fabre Pierre Dermo Cosmetique	5,6,5’,6’-tétraphényl-3,3’-(1,4-phénylène)-bis[1,2,4]triazine pour améliorer l’aspect des cicatrices et/ou réduire les marques cicatricielles

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69019956T2 (de) *	1989-10-06	1995-11-23	Janos Szabo	Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen, insbesondere pyogener und atopischer dermatitis und verfahren zu deren herstellung.
CH680045A5 (es) *	1990-02-16	1992-06-15	Om Lab Sa
BR9608500A (pt) *	1995-09-07	1999-07-06	Oreal	Utilização de pelo menos um extrato de pelo menos uma bactéria filamentosa não fotossintética composição cosmética ou farmacêutica e processo de tratamento cosméstico
AU2003239125A1 (en) *	2002-03-20	2003-10-08	Emory University	Neisseria mutants, lipooligosaccharides and immunogenic compositions
GB0321615D0 (en) *	2003-09-15	2003-10-15	Glaxo Group Ltd	Improvements in vaccination
WO2005030133A2 (en) *	2003-09-22	2005-04-07	Yale University	Treatment with agonists of toll-like receptors
US7244607B2 (en) *	2003-10-01	2007-07-17	The United States Of America, As Represented By The Secretary Of Agriculture	Chromobacterium subtsugae sp. nov. for control of insect pests
WO2008109669A2 (en) *	2007-03-05	2008-09-12	Om Pharma	Bacterial extract for respiratory disorders and proces for its preparation
FR2918883B1 (fr) *	2007-07-17	2010-01-15	Oreal	Utilisation d'un extrait bacterien cultive sur une eau thermale pour le traitement des peaux seches
FR2918885B1 (fr) *	2007-07-17	2009-08-28	Oreal	Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires
FR2918884B1 (fr) *	2007-07-17	2010-01-15	Oreal	Utilisation d'extraits bacteriens cultives sur eau thermale comme agent anti-rougeur
EP2274320A1 (en) *	2008-04-25	2011-01-19	ID Biomedical Corporation of Quebec	Methods for preparing immunogenic compositions
JP2011519834A (ja)	2008-04-25	2011-07-14	インスティチュートフォーシステムズバイオロジー	フラジェリンポリペプチドワクチン
SI22889A (sl)	2008-10-28	2010-04-30	Kemijski inštitut	Himerni flagelini za cepiva
WO2010135704A2 (en)	2009-05-22	2010-11-25	Institute For Systems Biology	Secretion-related bacterial proteins for nlrc4 stimulation
KR101762610B1 (ko) *	2010-11-05	2017-08-04	삼성전자주식회사	이동 통신 시스템에서 역방향 스케줄링 및 그를 위한 정보 전송 방법 및 장치

2010
- 2010-12-22 FR FR1061081A patent/FR2969657B1/fr active Active
2011
- 2011-12-21 AR ARP110104841A patent/AR084454A1/es active IP Right Grant
- 2011-12-21 TW TW100147712A patent/TW201307551A/zh unknown
- 2011-12-22 GE GEAP201113131A patent/GEP201606589B/en unknown
- 2011-12-22 NZ NZ612294A patent/NZ612294A/en unknown
- 2011-12-22 AU AU2011347254A patent/AU2011347254B2/en active Active
- 2011-12-22 DK DK11802426.4T patent/DK2655595T3/en active
- 2011-12-22 PT PT11802426T patent/PT2655595T/pt unknown
- 2011-12-22 UA UAA201309001A patent/UA113399C2/uk unknown
- 2011-12-22 MX MX2013007217A patent/MX345125B/es active IP Right Grant
- 2011-12-22 PH PH1/2013/501267A patent/PH12013501267A1/en unknown
- 2011-12-22 ES ES11802426.4T patent/ES2689138T3/es active Active
- 2011-12-22 US US13/997,029 patent/US9084811B2/en active Active
- 2011-12-22 SG SG2013047055A patent/SG191236A1/en unknown
- 2011-12-22 PL PL11802426T patent/PL2655595T3/pl unknown
- 2011-12-22 CA CA2821653A patent/CA2821653C/en active Active
- 2011-12-22 RU RU2013132895A patent/RU2612790C2/ru active
- 2011-12-22 KR KR1020137016743A patent/KR102043472B1/ko active Active
- 2011-12-22 WO PCT/EP2011/073747 patent/WO2012085182A1/en not_active Ceased
- 2011-12-22 EP EP11802426.4A patent/EP2655595B1/en active Active
- 2011-12-22 CN CN201180062363.2A patent/CN103403144B/zh active Active
- 2011-12-22 JP JP2013545395A patent/JP6117111B2/ja active Active
- 2011-12-22 MY MYPI2013002355A patent/MY173066A/en unknown
2013
- 2013-06-10 TN TNP2013000249A patent/TN2013000249A1/fr unknown
- 2013-06-13 ZA ZA2013/04355A patent/ZA201304355B/en unknown
- 2013-06-13 IL IL226943A patent/IL226943B/en active IP Right Grant
- 2013-06-13 MA MA36009A patent/MA34734B1/fr unknown
- 2013-06-17 CO CO13144310A patent/CO6741177A2/es unknown
- 2013-06-21 CL CL2013001853A patent/CL2013001853A1/es unknown
2015
- 2015-02-19 US US14/626,589 patent/US9662357B2/en active Active
2017
- 2017-01-12 JP JP2017003631A patent/JP2017099393A/ja active Pending

Also Published As

Publication number	Publication date
JP2017099393A (ja)	2017-06-08
ZA201304355B (en)	2014-11-26
CN103403144A (zh)	2013-11-20
IL226943B (en)	2019-02-28
RU2612790C2 (ru)	2017-03-13
CO6741177A2 (es)	2013-08-30
AR084454A1 (es)	2013-05-15
PH12013501267A1 (en)	2013-08-28
NZ612294A (en)	2015-05-29
CA2821653A1 (en)	2012-06-28
KR102043472B1 (ko)	2019-11-11
CA2821653C (en)	2020-03-10
BR112013015998A2 (pt)	2017-04-11
GEP201606589B (en)	2017-01-10
AU2011347254B2 (en)	2016-07-14
MX345125B (es)	2017-01-17
RU2013132895A (ru)	2015-01-27
US9662357B2 (en)	2017-05-30
PL2655595T3 (pl)	2019-07-31
US20130316033A1 (en)	2013-11-28
UA113399C2 (xx)	2017-01-25
FR2969657A1 (fr)	2012-06-29
MX2013007217A (es)	2014-01-08
KR20140030109A (ko)	2014-03-11
SG191236A1 (en)	2013-07-31
ES2689138T3 (es)	2018-11-08
PT2655595T (pt)	2018-11-02
US20150231187A1 (en)	2015-08-20
DK2655595T3 (en)	2018-10-08
MY173066A (en)	2019-12-23
HK1187366A1 (zh)	2014-04-04
JP2014503211A (ja)	2014-02-13
MA34734B1 (fr)	2013-12-03
TN2013000249A1 (en)	2014-11-10
US9084811B2 (en)	2015-07-21
EP2655595B1 (en)	2018-07-04
WO2012085182A1 (en)	2012-06-28
AU2011347254A1 (en)	2013-07-11
EP2655595A1 (en)	2013-10-30
JP6117111B2 (ja)	2017-04-19
CN103403144B (zh)	2015-11-25
FR2969657B1 (fr)	2014-02-07
TW201307551A (zh)	2013-02-16

Publication	Publication Date	Title
CL2013001853A1 (es)	2014-03-28	Bacteria no patogena gram negativa perteneciente a la clase betaproteobacteria y subfamilia neisseriaceae; extracto que la comprende; composicion que comprende a la bacteria o al extracto; y su uso para tratar o prevenir trastornos inflamatorios dermatologicos.
CL2014002348A1 (es)	2015-01-23	Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado.
BR112015002933A2 (pt)	2018-06-12	dispositivo implantável para uso no corpo humano e/ou animal para substituir uma válvula de um órgão.
CL2013000238A1 (es)	2014-03-28	Uso de inhibores de la succinato deshidrogenasa y/o inhibidores del complejo iii para mejorar la relacion entre microorganismos dañinos y beneficiosos.
CL2012001950A1 (es)	2013-01-11	Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
BR112013023600A2 (pt)	2017-03-01	bactérias probióticas tendo atividade antioxidante e uso das mesmas
BR112013013402A2 (pt)	2016-07-12	combinações de ingredientes ativos que compreendem piridiletilbenzamidas e outros ingredientes ativos
BR112016011830A2 (pt)	2017-09-26	composições bacterianas sinergísticas e métodos para produção e uso das mesmas.
BRPI0911715A2 (pt)	2019-09-24	partículas ativas para aplicações bio-analíticas e métodos para sua preparação.
CO6440531A2 (es)	2012-05-15	2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
BR112013015592A2 (pt)	2016-07-12	dericados de biciclo-[3.2.1]-octilamida e usos dos mesmos
BR112013001423A2 (pt)	2016-05-24	método, método in vitro, uso e kit útil para realizar o método
CL2013000801A1 (es)	2013-11-29	Composicion farmaceutica que comprende un inhibidor de rankl y una hormona o un derivado de la misma, y uso del inhibidor rankl para preparar dicha composicion
IT1403847B1 (it)	2013-11-08	Composizioni farmaceutiche comprendenti rifaximina e loro uso.
BR112013014441A2 (pt)	2016-09-13	microrganismo tendo uma melhor capacidade de produzir ornitina e método para produzir ornitina usando o mesmo
ES2571105T3 (es)	2016-05-24	Modulador
BRPI1006480A2 (pt)	2016-03-01	sistema configurado para ajustar o volume tidal da respiração de um indivíduo que respira sozinho e método para ajustar o volume tidal da respiração de um indivíduo que respira sozinho.
BRPI0912687A2 (pt)	2016-01-26	uso de bactéria probiótica para o tratamento de hiperhomocisteinaemia
BR302012005088S1 (pt)	2014-06-03	"configuração aplicada em dispositivo para elevador."
EP2913111A4 (en)	2015-10-14	MILLING ROLL TRANSFER MECHANISM AND MILL WITH MECHANISM
CL2014003525A1 (es)	2015-04-10	Composicion farmaceutica que comprende fimasartan, hidroclorotiazida y un aglutinante; procedimiento de preparacion; su uso en el tratamiento de hipertension.
PT2732157T (pt)	2019-06-04	Depósito de acumulação de pressão elástica, hidráulica ou pneumática e sua aplicação em instalações de energia eólica
PT2408913T (pt)	2017-03-07	Péptidos neil3 e vacinas que incluem os mesmos
BR112014014973A2 (pt)	2017-06-13	preparações contendo emodepside amorfo
CL2013001313A1 (es)	2014-03-07	Composicion que comprende microorganismos probióticos no replicantes para prevenir o tratar infecciones gastrointestinales